Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8K Hold
500
﹤0.01% 3465
2026
Q1
$7.31K Hold
500
﹤0.01% 3479
2025
Q4
$6.32K Buy
500
+400
+400% +$5.9K ﹤0.01% 3612
2025
Q3
$1.54K Sell
100
-27
-21% -$435 ﹤0.01% 3825
2025
Q2
$2K Hold
127
﹤0.01% 3622
2025
Q1
$2.43K Hold
127
﹤0.01% 3468
2024
Q4
$3.03K Hold
127
﹤0.01% 3363
2024
Q3
$3.56K Hold
127
﹤0.01% 3263
2024
Q2
$3.32K Sell
127
-143
-53% -$2.97K ﹤0.01% 3210
2024
Q1
$5.9K Hold
270
﹤0.01% 3080
2023
Q4
$6.28K Buy
270
+127
+89% +$2.56K ﹤0.01% 3042
2023
Q3
$2.82K Hold
143
﹤0.01% 2972
2023
Q2
$3.24K Hold
143
﹤0.01% 2955
2023
Q1
$2.81K Sell
143
-1,418
-91% -$27.2K ﹤0.01% 2951
2022
Q4
$21.2K Buy
+1,561
New +$27.7K ﹤0.01% 2103

Other funds holding RXO

NewEdge Advisors's RXO Position: Q2 2026 in Review

NewEdge Advisors held its RXO (RXO) position steady in Q2 2026 at 500 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3465.

NewEdge Advisors first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $21.2K in Q4 2022. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • NewEdge Advisors held 500 shares of RXO worth $13.8K as of Q2 2026.
  • NewEdge Advisors left its RXO share count unchanged in Q2 2026.
  • RXO made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3465 holding.
  • NewEdge Advisors first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's RXO position peaked at $21.2K in Q4 2022.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.